Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-07 Tax Withholding |
2025-03-11 5:49 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Wargacki Stephen Chief Science Officer |
28,290 | $2.65 | 408,552 (Direct) |
View |
| 2025-03-07 Option Award |
2025-03-11 5:49 pm |
N/A 2035-03-07 |
Aquestive Therapeutics Inc. | AQST | Wargacki Stephen Chief Science Officer |
180,000 | $0 | 408,552 (Direct) |
View |
| 2025-03-10 Tax Withholding |
2025-03-11 5:49 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Wargacki Stephen Chief Science Officer |
4,572 | $2.54 | 408,552 (Direct) |
View |
| 2024-03-09 Tax Withholding(A) |
2024-10-02 2:15 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Wargacki Stephen Chief Science Officer |
19,505 | $4.88 | 261,414 (Direct) |
View |
| 2024-05-10 Option Award |
2024-05-13 1:40 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Wargacki Stephen Chief Science Officer |
10,000 | $0 | 267,963 (Direct) |
View |
| 2024-03-09 Tax Withholding |
2024-03-12 1:46 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Wargacki Stephen SVP, Research & Development |
12,956 | $4.88 | 257,963 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-11 10:34 am |
N/A 2034-03-07 |
Aquestive Therapeutics Inc. | AQST | Wargacki Stephen SVP, Research & Development |
168,750 | $0 | 327,169 (Direct) |
View |
| 2023-03-10 Tax Withholding |
2024-03-11 10:34 am |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Wargacki Stephen SVP, Research & Development |
1,981 | $0.7937 | 327,169 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-09 4:30 pm |
N/A 2026-05-05 |
Aquestive Therapeutics Inc. | AQST | Wargacki Stephen SVP, Research & Development |
67,500 | $0 | 67,500 (Direct) |
View |
| 2023-05-05 Option Award |
2023-05-05 4:00 pm |
N/A 2026-05-05 |
Aquestive Therapeutics Inc. | AQST | Wargacki Stephen SVP, Research & Development |
67,500 | $0 | 67,500 (Direct) |
View |
| 2023-03-09 Option Award |
2023-03-09 3:06 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Wargacki Stephen SVP, Research & Development |
135,000 | $0 | 161,956 (Direct) |
View |
Ownership |
2023-01-11 4:05 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Wargacki Stephen SVP, Research & Development |
0 | $0 | 125,456 (Direct) |
View |